About Proxim Diagnostics
Proxim Diagnostics is a company based in Sunnyvale (United States) founded in 2010. Proxim Diagnostics has raised $22.9 million across 5 funding rounds from investors including BioMerieux. Proxim Diagnostics offers products and services including Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test. Proxim Diagnostics operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
- Headquarter Sunnyvale, United States
- SectorsHealthcare
- Email••••••••
- Website proximdx.com
- Social LinkedIn
- Legal Name Proxim Diagnostics Corporation
- Total Equity Funding$22.9M (USD)
in 5 rounds
- Investors
Products & Services of Proxim Diagnostics
Proxim Diagnostics offers a comprehensive portfolio of products and services, including Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test.
Portable device for accurate immunodiagnostic testing using whole blood.
Low-cost cartridges designed for various diagnostic tests.
Quantitative blood test for detecting pregnancy levels.
Blood test to identify sepsis markers in patients.
Funding Insights of Proxim Diagnostics
Proxim Diagnostics has successfully raised a total of $22.9M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.9M
- Total Rounds 5
- First Round $922,543
(Nov 2010)
- Investors Count 1
All 5 funding rounds of Proxim Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | – | Series B | – | BioMerieux | – |
| Nov 2022 | $18M | Series B | – | – | – |
| Sep 2018 | $1.71M | Series A | – | – | – |
| Mar 2016 | $2.27M | Series A | – | – | – |
| Nov 2010 | $922,543 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Proxim Diagnostics
Proxim Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BioMerieux.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of diagnostics devices for multiple health purposes | 1963 | biomerieux.com | - |
Investor details for Proxim Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Proxim Diagnostics
8 people are tracked at Proxim Diagnostics (4 in leadership, 2 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Duane Yamasaki | Vice President Of Product Engineering | Leadership |
Travis Wong | Director of Manufacturing Operations | Leadership |
Mikhail Briman | CEO, Co-Founder & Board Director | Leadership |
Sergey Belonozhko, MBA | Director | Leadership |
Thomas Shannon | Director | Board & advisors |
Sergey Belonozhko | Chairman | Board & advisors |
Bin Qian | Manager | Team |
Sang Nguyen | Staff Manufacturing Engineer | Team |
Complete people profiles for Proxim Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Proxim Diagnostics
3 dated milestones of Proxim Diagnostics across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Proxim Diagnostics is founded.
- Funding First funding round of $923K.
- Funding Latest funding round, Series B,.
Competitors of Proxim Diagnostics
Proxim Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| lepumedical.com | 1999 | Beijing, China | – | – | Interventional cardiology devices are developed and marketed globally. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. |
Detailed competitors of Proxim Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Proxim Diagnostics
The website of Proxim Diagnostics (proximdx.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 148% vs previous month
Latest news on Proxim Diagnostics
Complete news archive for Proxim Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Proxim Diagnostics
10 companies that operate in the same segment as Proxim Diagnostics (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Proxim Diagnostics
Proxim Diagnostics was founded in 2010.
Proxim Diagnostics is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Proxim Diagnostics is a funded company, having raised a total of $22.9M across 5 funding rounds to date. The company's 1st funding round was a Seed of $922.54K, raised on Nov 2010.
Proxim Diagnostics was founded in 2010 and is based in Sunnyvale, United States. Operations focus on the medical diagnostics sector, where a handheld immunodiagnostic device is developed for detecting cardiac vascular diseases. Capabilities include testing for cardiac markers, blood gases, electrolytes, metabolites, as well as infectious disease antigens and antibodies. The device supports point-of-care applications in healthcare settings.
Proxim Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Proxim Diagnostics offers Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test.
Proxim Diagnostics has 1 investor. Key investors include BioMerieux.
Proxim Diagnostics operates through Proxim Diagnostics Corporation.